HLA-B27 homodimers differ in their interactions with LILRB1, LILRB2, KIR3DL1 and KIR3DL2 compared to HLA-B27 heterotrimers

被引：0
|
作者：
Giles, J. [1 ]
Shaw, J. [1 ]
Kollnberger, S. [1 ]
McHugh, K. [1 ]
Payeli, S. [2 ]
Renner, C. [2 ]
Maenaka, K. [3 ]
Bowness, P. [1 ,4 ]
机构：
[1] Univ Oxford, Weatherall Inst Mol Med, Human Immunol Unit, Oxford, England
[2] Univ Zurich, Dept Oncol, Zurich, Switzerland
[3] Hokkaido Univ, Lab Biomol Sci, Sapporo, Hokkaido 060, Japan
[4] Univ Oxford, Nuffield Orthopaed Ctr, Oxford, England
来源：
IMMUNOLOGY | 2010年 / 131卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：60 / 60
页数：1
相关论文
共 50 条
  • [31] Different and divergent regulation of the KIR2DL4 and KIR3DL1 promoters
    Stewart, CA
    van Bergen, J
    Trowsdale, J
    JOURNAL OF IMMUNOLOGY, 2003, 170 (12): : 6073 - 6081
  • [32] Pemphigus is associated with KIR3DL2 expression levels and provides evidence that KIR3DL2 may bind HLA-A3 and A11 in vivo
    Augusto, Danillo G.
    O'Connor, Geraldine M.
    Lobo-Alves, Sara C.
    Bass, Sara
    Martin, Maureen P.
    Carrington, Mary
    McVicar, Daniel W.
    Petzl-Erler, Maria Luiza
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2015, 45 (07) : 2052 - 2060
  • [33] KIR3DL1 and HLA-B Density and Binding Calibrate NK Education and Response to HIV
    Boudreau, Jeanette E.
    Mulrooney, Tiernan J.
    Le Luduec, Jean-Benoit
    Barker, Edward
    Hsu, Katharine C.
    JOURNAL OF IMMUNOLOGY, 2016, 196 (08): : 3398 - 3410
  • [34] Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific
    Hansasuta, P
    Dong, T
    Thananchai, H
    Weekes, M
    Willberg, C
    Aldemir, H
    Rowland-Jones, S
    Braud, VM
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (06) : 1673 - 1679
  • [35] Uterine NK cells underexpress KIR2DL1/S1 and LILRB1 in reproductive failure
    Woon, Ee Von
    Nikolaou, Dimitrios
    MacLaran, Kate
    Norman-Taylor, Julian
    Bhagwat, Priya
    Cuff, Antonia O. O.
    Johnson, Mark R. R.
    Male, Victoria
    FRONTIERS IN IMMUNOLOGY, 2023, 13
  • [36] Prognostic Value of KIR2DS1 and KIR3DL1 is not confirmed
    Krome, Susanne
    TRANSFUSIONSMEDIZIN, 2020, 10 (02)
  • [37] Cutting edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B
    Thananchai, Hathairat
    Gillespie, Geraldine
    Martin, Maureen P.
    Bashirova, Arman
    Yawata, Nobuyo
    Yawata, Makoto
    Easterbrook, Philippa
    McVicar, Daniel W.
    Maenaka, Katsumi
    Parham, Peter
    Carrington, Mary
    Dong, Tao
    Rowland-Jones, Sarah
    JOURNAL OF IMMUNOLOGY, 2007, 178 (01): : 33 - 37
  • [38] The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09
    Cauli, Alberto
    Shaw, Jacqueline
    Giles, Joanna
    Hatano, Hiroko
    Rysnik, Oliwia
    Payeli, Sravan
    McHugh, Kirsty
    Dessole, Grazia
    Porru, Giovanni
    Desogus, Elisabetta
    Fiedler, Sarah
    Holper, Soraya
    Carette, Amanda
    Blanco-Gelaz, Miguel Angel
    Vacca, Alessandra
    Piga, Matteo
    Ibba, Valentina
    Garau, Pietro
    La Nasa, Giorgio
    Lopez-Larrea, Carlos
    Mathieu, Alessandro
    Renner, Christoph
    Bowness, Paul
    Kollnberger, Simon
    RHEUMATOLOGY, 2013, 52 (11) : 1952 - 1962
  • [39] Uterine NK cells underexpress KIR2DL1/S1 and LILRB1 receptors recognizing HLA-C2 and HLA-G on extravillous trophoblasts in reproductive failure
    Woon, E. V.
    Nikolaou, D.
    MacLaran, K.
    Norman-Taylor, J.
    Johnson, M.
    Male, V.
    HUMAN REPRODUCTION, 2024, 39
  • [40] Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab
    Erbe, Amy K.
    Wang, Wei
    Carmichael, Lakeesha
    Hoefges, Anna
    Grzywacz, Bartosz
    Reville, Patrick K.
    Ranheim, Erik A.
    Hank, Jacquelyn A.
    Kim, KyungMann
    Seo, Songwon
    Mendonca, Eneida A.
    Song, Yiqiang
    Kenkre, Vaishalee P.
    Hong, Fangxin
    Gascoyne, Randy D.
    Paietta, Elisabeth
    Horning, Sandra J.
    Miller, Jeffrey S.
    Kahl, Brad
    Sondel, Paul M.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
12345